Teva Pharmaceutical Industries (TEVA) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 52.0%
EBITDA Margin: 0.2%
Op. Margin: -5.6%
Net Margin: -13.9%

Op. margin of -5.6% is down 16.5% YoY — costs are rising relative to revenue. Net margin at -13.9% and gross margin of 52.0% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit